TARDBP and amyotrophic lateral sclerosis: These data align with previous work highlighting that the distribution and severity of TDP-43 pathology relate to the clinical expression of dementia and motor impairments across the spectrum of TDP-43 proteinopathies40-42 and provide important cross-validation for our clinical designations of ALS, FTD, and subsequent features.